Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • SWKS vs MRNA✓SelectedUSD · MRNASWKS vs MRNA performance historyLatest closeAs of-4.07%11/18
Stock and ETF performance explorer

SWKS vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-41.8%
MRNA return
-20.0%
Excess return
-21.8%
Maximum drawdown
-67.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-4.1%-4.8%+0.8%-3.7%
7D-5.9%-20.9%+14.9%-4.3%
30D+2.7%-13.3%+16.0%+3.5%
3M+22.2%+212.6%-190.3%+3.5%
6M+18.2%+309.0%-290.9%-6.4%
YTD+32.7%+567.3%-534.6%-7.5%
1Y+35.0%+689.7%-654.7%-9.7%
3Y-3.6%+157.4%-161.0%-24.9%
5Y-41.8%-21.7%-20.1%-50.7%
All-41.8%-20.0%-21.8%-50.7%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling